5470-27-9 Usage
Uses
Used in Pharmaceutical Industry:
(2alpha,5alpha)-2-methylandrostane-3,17-dione is used as a pharmaceutical agent for the treatment of various conditions related to androgen deficiency or imbalance. It helps in managing symptoms such as low libido, muscle wasting, and osteoporosis.
Used in Sports and Fitness Industry:
(2alpha,5alpha)-2-methylandrostane-3,17-dione is used as a performance-enhancing substance by athletes and bodybuilders to increase muscle mass, strength, and physical performance. However, it is important to note that the use of this substance for such purposes may be prohibited by sports governing bodies due to its potential for abuse and health risks.
Used in Research and Development:
(2alpha,5alpha)-2-methylandrostane-3,17-dione is used as a research compound in the development of new drugs and therapies targeting androgen-related conditions. It helps scientists understand the mechanisms of action and potential applications of androgens in various physiological processes.
Check Digit Verification of cas no
The CAS Registry Mumber 5470-27-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,4,7 and 0 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 5470-27:
(6*5)+(5*4)+(4*7)+(3*0)+(2*2)+(1*7)=89
89 % 10 = 9
So 5470-27-9 is a valid CAS Registry Number.
5470-27-9Relevant academic research and scientific papers
Templeton,Kim
, p. 371 - 381 (1977)
The neutral urinary excretion products of 17beta-hydroxy-2alpha-methyl-5alpha-androstan-3-one from the rabbit dosed orally were investigated. Together with oxidation-reduction of the oxygen functions at C-3 and C-17 hydroxylation occurred at C-15, C-16, and at the 2alpha-methyl positions of the steroid nucleus.
NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF
-
, (2015/02/02)
Described herein are neuroactive steroids of the Formula (I): (Formula (I)) or a pharmaceutically acceptable salt thereof; wherein R1a and R1b are as defined herein. Such compounds are envisioned, in certain embodiments, to behave as GABA modulators. The present invention also provides pharmaceutical compositions comprising a compound of the present invention and methods of use and treatment, e.g., such for inducing sedation and/or anesthesia.
